Crossmark

Integrative analysis of a novel signature incorporating metabolism and stemness-related genes for risk stratification and assessing clinical outcomes and therapeutic responses in lung adenocarcinoma

Crossref DOI link: https://doi.org/10.1186/s12885-025-13984-6

Published Online: 2025-04-01

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Zheng, Wanrong

Zhou, Chuchu

Xue, Zixin

Qiao, Ling

Wang, Jianjun

Lu, Feng
License Information

Text and Data Mining valid from 2025-04-01

Version of Record valid from 2025-04-01
More Information

Article History

Received: 4 September 2024

Accepted: 20 March 2025

First Online: 1 April 2025

Declarations

:

: Our research adheres to the Declaration of Helsinki. The studies involving human participants were reviewed and approved by the Ethics Committee of Medical School of Henan University, China (HUSOM-2018-282). Informed consent was obtained from all subjects involved in the study. The animal study was reviewed and approved by the Ethic Committee of Medical School of Henan University.

: Not applicable.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below